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Introduction
Inherited dystrophinopathies (Becker and Duchenne mus-
cular dystrophy, and females with heterozygous mutations)
have a high rate of myocardial disease with a variable clini-
cal phenotype. We have previously demonstrated that dys-
trophinopathic patients have significantly impaired
myocardial energetics and fibrosis even in the presence of
normal left ventricular ejection fraction. Furthermore,
Coxsackie B3 induced viral cardiomyopathy has been
shown to be a form of acquired dystrophinopathy.
Purpose
We therefore acquired 31-Phosphorus magnetic reso-
nance spectroscopy (MRS), proton MRS and tagging to
determine the relationship between energetics, lipidosis,
fibrosis and regional systolic myocardial strain in
patients with inherited dystrophinopathies with and
without prior exposure to Coxsackie B3.
Methods
Patients (n=22; age 40±12yrs) with dystrophinopathy
and preserved ejection fraction (16 males with Becker
muscular dystrophy and 6 females with heterozygous
mutations; LVEF 65±6%) were scanned using a Siemens
Tim Trio 3 T. ELISA IgG assays were performed to
determine prior exposure to Coxsackie B. 31P MRS was
used to measure the cardiac phosphocreatine to adeno-
sine triphosphate ratio (PCr/ATP) and proton MRS was
used to interrogate the myocardial lipid/water ratio (%),
both in the mid-ventricular septum (Figure 1 and 2).
Results were compared to those from healthy volunteers
(n=22). Tagging images (vertical long axis and short axis
stack) were acquired to calculate regional strain and tor-
sion (CimTag2D v.7) (Figure 2). Late gadolinium
enhancement (LGE) was quantified using QMASS 7.0
software using threshold of 4 standard deviations above
unaffected myocardium.
Results
PCr/ATP ratios were significantly impaired in dystro-
phinopathic patients (1.6±0.2 vs healthy 2.1±0.3;
P=5x10-5). Peak systolic circumferential strain in the
mid ventricular septum was impaired in patients with
dystrophinopathy (14.1±5.0) compared with healthy
controls (18.7±1.8; P=4x10-4) and declined with
impaired PCr/ATP ratio (R2=0.51; P<0.001; Figure 3).
Proton spectroscopy was performed in the last 11/22
patients and revealed pronounced lipidosis (1.1±0.2%
vs. Normals 0.5±0.2%, P<0.001, lipid %=100xlipid/water
amplitude). LGE was detected in the lateral wall of 19/
22 patients (average 14.7±9%), with no septal fibrosis
detected in any patient. Increasing fibrosis did not cor-
relate with impaired energetics, but was significantly
higher in positive for Coxsackie B IgG (25±7% vs
10±7%; P=0.001).
Conclusions
Abnormal myocardial energetics is strongly associated
with impaired regional contractility in dystrophinopathies.
Myocardial fibrosis, on the other hand, is increased with Unversity of Oxford, Oxford, UK
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evidence for a two-hit interaction between inherited
and acquired mechanisms of myocardial damage in
dystrophinopathies.
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Figure 1 Typical 31-P MRS and proton MRS acquisition in a patient with dystophinopathy.
Figure 2 A: 31-Phosphorus energetics spectral voxels; B: Proton spectroscopy voxel; C: Short axis tagging (red border delineates septal region of
interst); D: late gadolinium imaging.
Figure 3 Septal peak systolic circumferential strain vs. phospocreatine
to adenosine tri-phosphate (PCr/ATP) ratio in patients with
dystronphinopathy.
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